1. Home
  2. EYPT vs ARCO Comparison

EYPT vs ARCO Comparison

Compare EYPT & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.23

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Arcos Dorados Holdings Inc. Shares

ARCO

Arcos Dorados Holdings Inc. Shares

HOLD

Current Price

$7.90

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
ARCO
Founded
1987
2007
Country
United States
Uruguay
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Restaurants
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2005
2011

Fundamental Metrics

Financial Performance
Metric
EYPT
ARCO
Price
$16.23
$7.90
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$28.75
$8.60
AVG Volume (30 Days)
1.2M
890.2K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
3.03%
EPS Growth
N/A
69.06
EPS
N/A
1.16
Revenue
$42,339,000.00
$4,555,936,000.00
Revenue This Year
N/A
$6.35
Revenue Next Year
N/A
$7.64
P/E Ratio
N/A
$6.79
Revenue Growth
N/A
1.21
52 Week Low
$3.91
$6.51
52 Week High
$19.11
$8.52

Technical Indicators

Market Signals
Indicator
EYPT
ARCO
Relative Strength Index (RSI) 46.21 68.05
Support Level $16.67 $7.58
Resistance Level $18.20 $7.92
Average True Range (ATR) 1.01 0.15
MACD -0.31 0.06
Stochastic Oscillator 2.85 95.83

Price Performance

Historical Comparison
EYPT
ARCO

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: